Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Oct/20/2020 Oct/26/2020 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/26/2020 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/29/2020 0
Grazoprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 Sep/26/2020 0
Paritaprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 Sep/29/2020 0
[((5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE)] Potential treatment - theoretical effect Experimental Antiviral Sep/02/2020 Sep/26/2020 0
Streptolydigin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/02/2020 Sep/26/2020 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/29/2020 Sep/26/2020 0
Cetirizine Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/29/2020 Sep/26/2020 0
SYN_15517940 Potential treatment - theoretical effect Experimental Antiviral Aug/28/2020 Sep/26/2020 0